The Journal of
Clinical Psychiatry

Obsessive-Compulsive and Related Disorders

Article June 1, 2002

Obsessive-Compulsive Disorder: Defining the Phenotype

Gerald Nestadt, MBBCh, MPH; Jack F. Samuels, PhD; Mark A. Riddle, MD; O. Joseph Bienvenu, MD, PhD; Kung-Yee Liang, PhD; Marco A. Grados, MD, MS; Bernadette Cullen, MBBCh

J Clin Psychiatry 2002;63(suppl 6):5-7

Article Abstract

Characterizing the obsessive-compulsive disorder (OCD) phenotype is important for treatment andetiologic studies. This article describes a family-study approach for identifying the spectrum of conditionsrelated to OCD and subtyping OCD cases into homogeneous subtypes.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Related Articles